Oystein T. Forre
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis.
Journal: PloS one
Published: April 20, 2021
Tumor necrosis factor inhibitors are associated with reduced complement activation in spondylarthropathies: An observational study.
Journal: PloS one
Published: March 24, 2019
Mortality and causes of death across the systemic connective tissue diseases and the primary systemic vasculitides.
Journal: Rheumatology (Oxford, England)
Published: May 11, 2018
The association of PTPN22 rs2476601 with juvenile idiopathic arthritis is specific to females.
Journal: Genes and immunity
Published: May 21, 2015
Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.
Journal: Nature medicine
Published: February 22, 2015
Genetic sharing and heritability of paediatric age of onset autoimmune diseases.
Journal: Nature communications
Published: February 14, 2015
Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1.
Journal: Nature communications
Published: February 08, 2015
ERAP2 is associated with ankylosing spondylitis in HLA-B27-positive and HLA-B27-negative patients.
Journal: Annals of the rheumatic diseases
Published: February 05, 2015
Rapid Anti-Inflammatory Effects of Gonadotropin-Releasing Hormone Antagonism in Rheumatoid Arthritis Patients with High Gonadotropin Levels in the AGRA Trial.
Journal: PloS one
Published: December 30, 2014
Variants in CXCR4 associate with juvenile idiopathic arthritis susceptibility.
Journal: BMC medical genetics
Published: August 20, 2014
Epistasis amongst PTPN2 and genes of the vitamin D pathway contributes to risk of juvenile idiopathic arthritis.
Journal: The Journal of steroid biochemistry and molecular biology
Published: August 15, 2014
Generalized bone loss in early rheumatoid arthritis patients followed for ten years in the biologic treatment era.
Journal: BMC musculoskeletal disorders
Published: June 20, 2014
Last Updated: 09/26/2026